These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Kalapurakal JA, Nan B, Norkool P, Coppes M, Perlman E, Beckwith B, Ritchey M, Breslow N, Grundy P, D'angio GJ, Green DM, Thomas PR. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1379-84. PubMed ID: 15590168 [Abstract] [Full Text] [Related]
7. [Treatment of advanced Wilms' tumor]. Li MJ, Huang Y, Tang DX, Zhou YB, Tang HF, Liang JF. Zhonghua Zhong Liu Za Zhi; 2006 Oct 01; 28(10):791-5. PubMed ID: 17366799 [Abstract] [Full Text] [Related]
8. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. Metzger ML, Stewart CF, Freeman BB, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. J Clin Oncol; 2007 Jul 20; 25(21):3130-6. PubMed ID: 17634492 [Abstract] [Full Text] [Related]
17. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour. Liu WG, Gu WZ, Zhou YB, Tang HF, Li MJ, Ma WX. Eur J Clin Invest; 2008 Dec 20; 38(12):931-8. PubMed ID: 19021718 [Abstract] [Full Text] [Related]